May 14 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:
ARS PHARMACEUTICALS Q1 OPERATING INCOME USD -37.177 MILLION VERSUS. IBES ESTIMATE USD -37.1 MILLION
ARS PHARMACEUTICALS Q1 OPERATING EXPENSES USD 45.15 MILLION
ARS PHARMACEUTICALS Q1 REVENUE USD 7.763 MILLION VERSUS. IBES ESTIMATE USD 7.48 MILLION
ARS PHARMACEUTICALS Q1 NET INCOME USD -33.94 MILLION VERSUS. IBES ESTIMATE USD -34.6 MILLION
ARS PHARMACEUTICALS Q1 BASIC EPS USD -0.35
ARS PHARMACEUTICALS Q1 CASH & INVESTMENTS USD 275.7 MILLION
Source text: ID:nGNX9W08PG
Further company coverage: SPRY.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.